NEUROShield

by In-Med Prognostics L3C  · Based in India → — AI-Powered Precision Neuroimaging
Neurology Neurosurgery Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

NEUROShield by In-Med Prognostics L3C is an FDA 510(k) cleared, fully automated brain geometry-based quantifying analytics tool and cloud platform. It leverages AI, Deep Net, and 3D Convolutional Networks to provide clinical decision support for neurologists, neuroradiologists, and neurosurgeons. The platform processes 3D MR images to automatically calculate brain volumes and offers comprehensive brain structure analysis, including ethnicity-specific reference ranges adjusted to age and gender.

NEUROShield assists physicians in devising optimal treatment plans for patients with neurodegenerative diseases such as Dementia, Alzheimer’s Disease, Parkinson’s, and Epilepsy, by enabling early detection of atrophy. Additionally, the NeuroShield CT TBI product provides AI-based neurotrauma screening and quantification, automating the detection and quantification of intracranial hemorrhage, fracture, and midline shift, which is crucial for rapid clinical decision-making in critical care. The tool aims to reduce the burden on radiologists by automating MRI imaging analysis and providing accurate, actionable results.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Fully automated brain geometry-based quantifying analytics
  • Utilizes AI/Deep Net/3D Convolutional Networks
  • Processes 3D MR images for brain volumetry
  • Calculates brain volumes and provides comprehensive brain structure analysis
  • Assists in treatment planning for neurodegenerative diseases
  • Offers ethnicity-specific reference ranges adjusted to age and gender
  • Supports early detection of atrophy in neurodegenerative disorders
  • Automates MRI imaging analysis to reduce radiologist workload
  • Cloud-based platform with centralized scan management
  • NeuroShield CT for AI-based neurotrauma screening and quantification (bleed, fracture, midline shift detection)

Use Cases

  • Clinical decision support for neurologists, neuroradiologists, and neurosurgeons
  • Diagnosis and management of neurodegenerative diseases (Dementia, Alzheimer's, Parkinson's, Epilepsy)
  • Early intervention and monitoring for neurodegenerative disorders
  • Neurotrauma screening, quantification, and triage management (TBI, intracranial hemorrhage, fracture, midline shift)
  • Automating image processing to improve efficiency in radiology workflows
  • Research support for clinical imaging-based projects and building databanks

What Physicians Need to Know

Brain MRI/CT Analysis
NEUROShield offers automated brain volumetry from 3D MRI using AI/Deep Net/3D Convolutional Networks. It provides comprehensive brain structure analysis with absolute volumes, intracranial volume (ICV) percentages, and age/gender/ethnicity-adjusted reference ranges across over 30 structures. The tool also includes NeuroShield CT TBI, an AI-based neurotrauma screening and quantification tool for Traumatic Brain Injury, which automates stroke lesion segmentation and midline shift detection. It is designed to streamline and enhance the diagnostic process by automating the segmentation and volumetric analysis of brain structures. The software has demonstrated high accuracy across various scanners, clinical subgroups, genders, ages, and slice thicknesses.
Neurodegenerative Disease Screening
NEUROShield assists physicians in devising treatment plans for patients with neurodegenerative diseases such as Dementia, Alzheimer's Disease, Parkinson's, and Epilepsy by automatically calculating brain volumes from 3D MR images. It can help detect atrophy early, allowing patients to benefit from newly discovered drugs. The tool provides ethnicity-specific reference ranges adjusted to age, gender, and ethnicity, aiming to bring precision medicine to neurodegenerative disease management.
Stroke Detection Speed
The NeuroShield CT TBI tool automates stroke lesion segmentation and midline shift detection, supporting rapid clinical decision-making in critical care. AI-based systems for stroke detection can analyze CT scans in 1-6 minutes, significantly faster than traditional radiology workflows (15-60 minutes). This can cut door-to-notification time by 30-52% in real-world hospital settings. AI in functional MRI automates detection, highlights abnormalities, and quantifies patterns to speed up stroke diagnostics. Early diagnosis is crucial in TBI cases, as 50% of associated mortalities occur within the first 24 hours.
Large Vessel Occlusion Detection
AI stroke detection systems achieve 90-95% accuracy for identifying large vessel occlusions (LVOs) and intracerebral hemorrhages.
Triage Prioritization Speed
NeuroShield CT TBI is integrated into clinical and radiology workflows to efficiently prioritize critical cases requiring immediate attention. It promptly alerts neurologists to the presence of critical pathologies, offering quantifiable insights essential for early intervention during the 'Golden Hour' post-trauma. This can lead to rapid, informed decision-making around workflow prioritization and acute triage management. An AI triage agent embedded in EHR systems can summarize relevant chart information, flag missing details, and recommend priority routing for cognitive concerns, potentially speeding up treatment for Alzheimer's disease patients.
Seizure Detection
NEUROShield assists in devising treatment plans for epilepsy patients by automatically calculating brain volumes from 3D MR images. AI and machine learning applications extend to recognizing seizure surrogates, detecting interictal epileptiform activity, and forecasting seizures for preemptive interventions. AI-powered point-of-care EEG is bringing real-time seizure detection to hospitals that previously lacked the technicians and specialists.
Physician Tip

NEUROShield serves as a clinical decision support tool for neurologists and neuroradiologists, providing automated brain volumetry from 3D MRI and neurotrauma screening from CT scans. It offers ethnicity-specific reference ranges, which can be adjusted for age and gender, to support precision medicine in neurodegenerative disease management. The tool aids in early detection of atrophy in neurodegenerative diseases like Dementia, Alzheimer's, Parkinson's, and Epilepsy, facilitating timely intervention with new drugs. For neurotrauma cases, NeuroShield CT TBI automates the detection and quantification of pathologies such as intracranial hemorrhage, fractures, and midline shifts, enabling rapid decision-making and prioritizing critical cases. This can reduce the burden on radiologists by automating MRI imaging analysis and providing accurate, actionable results.

NEUROShield is a cloud-based platform that utilizes AI/Deep Net/3D Convolutional Networks. The NeuroShield CT TBI product is integrated seamlessly into clinical and radiology workflows. The company also offers NeuroFlo, a neurology workflow software that streamlines clinical operations from scan intake to report delivery, aiming to reduce radiologist burden through intelligent automation and centralized data visualization.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentCloud-based platform; integrates with Modality, PACS, HMIS, RIS, and on-site/on-premise solutions.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

What the Web Says

NEUROShield by InMed.AI is an AI-powered, cloud-based platform designed to assist neurologists and neuroradiologists in diagnosing and managing neurodegenerative diseases like Alzheimer's, Parkinson's, dementia, and epilepsy. It uses 3D MRI images to automatically calculate brain volumes and detect atrophy, offering ethnicity-specific reference ranges. The tool has received U.S. FDA 510(k) clearance and is currently in clinical use in over 220 sites worldwide.

Overall: Positive

Strengths

  • Provides objective, quantitative, and actionable data for clinical decision-making.
  • Aids in early detection of brain atrophy, potentially allowing for timely intervention.
  • Reduces radiologists' burden by automating MRI imaging analysis.
  • Offers ethnicity-specific reference ranges adjusted for age and gender, promoting precision medicine.
  • Demonstrated high accuracy, reliability, and effectiveness in clinical trials across various scanner strengths and demographic subgroups.
  • Affordable and accessible, aiming to bring state-of-the-art healthcare tools to a wider population.

Limitations

  • No specific cons were found in the provided search results regarding NEUROShield by InMed.AI.
  • General concerns about AI in neuroimaging include a lack of prospective validation and integration into existing workflows.

Based on reviews from: trustradius.com, capterra.com, mpo-mag.com, itnonline.com, diagnosticimaging.com, inmed.ai, healthcareradius.in, appliedradiology.com, biospectrumindia.com, analyticsindiamag.com, fdaweb.com, auntminnie.com, europeanhhm.com, scribd.com, bioengineer.org, nih.gov, prnewswire.com, indiatimes.com, medicircle.in, youtube.com, g2.com, reddit.com

Last updated: 2026-10-30

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate NEUROShield

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

fdaweb.com
FDA Clears InMed.AI NeuroShield Tool
The FDA has granted 510(k) clearance to InMed.AI's NeuroShield, an AI-powered tool that uses 3D magnetic resonance images to calculate brain volumes, assisting physicians in treatment planning for neurodegenerative diseases. The clearance was based on a U.S.-based trial of 280 subjects that demonstrated the product's accuracy across various scanner types, clinical subgroups, and demographics.
2023-11
mpo-mag.com
InMed Prognostics Earns FDA Nod for NeuroShield Brain Volumetry Tool
InMed AI (InMed Prognostics) has received U.S. FDA 510(k) clearance for NeuroShield, an automated, brain geometry-based analytics tool that uses AI to support neurologists and neuroradiologists. The technology processes 3D MR images to calculate brain volumes, aiding in treatment plans for conditions like dementia, Alzheimer's, Parkinson's, and epilepsy.
2023-11
prnewswire.com
InMed AI Receives FDA 510(k) clearance for NeuroShield™
InMed AI announced on November 13, 2023, that it received FDA 510(k) clearance for NeuroShield, an AI-powered tool designed to quantify brain volumes using MRI data. This tool is noted as the first of its kind to offer ethnicity-specific reference ranges.
2023-11
biospectrumindia.com
AI-powered NeuroShield automatically quantifies brain volumes using MRI data
Pune-based InMed Prognostics Inc. received U.S. FDA 510(k) clearance for NeuroShield, an AI/Deep Net/3D Convolutional Networks-based tool for neurologists and neuroradiologists. NeuroShield processes 3D MR images to calculate brain volumes for neurodegenerative diseases and is the first in the world to provide age, gender, and ethnicity-adjusted reference ranges.
2023-11
appliedradiology.com
New AI-Powered Tool Automatically Quantifies Brain Volumes Using MR Data
InMed.AI's NeuroShield, a fully automated AI-powered platform, has received US FDA 510(k) clearance. It uses 3D MR images to calculate brain volumes, assisting in treatment plans for neurodegenerative diseases such as Dementia, Alzheimer's, Parkinson's, and Epilepsy.
2023-11
theaiinsider.tech
InMed AI Receives FDA 510(k) Clearance for NeuroShield™
InMed AI has secured FDA 510(k) clearance for its NeuroShield™ technology.
2023-11
diagnosticimaging.com
InMed.AI's NeuroShield gets FDA 510(k) clearance
NeuroShield, an AI-enabled brain volume quantification tool from InMed.AI, has received 510(k) clearance from the FDA. It aids in early detection of neurodegenerative conditions like dementia and Alzheimer's by providing automated brain volume assessment from 3D MRI scans.
2023-11
indiatimes.com
In-Med Prognostics launches NEUROShield, a brain quantifying analytics tool
In-Med Prognostics launched NEUROShield, a cloud-based Clinical Decision Support Tool for neurological disorders, in January 2020. This AI-powered tool uses 3D MRI images to provide volumetric analysis of the brain and its structures, aiding in early prognosis and differential diagnosis through pattern recognition and deep learning.
2020-01

Videos

Product demos, reviews, and walkthroughs for NEUROShield.

View all on YouTube

Frequently Asked Questions

NEUROShield, developed by InMed AI, is an AI-powered, cloud-based clinical decision support tool for neurologists and neuroradiologists. It uses AI/Deep Net/3D Convolutional Networks to analyze 3D MR images, automatically calculating brain volumes to help in devising treatment plans for neurodegenerative diseases such as dementia, Alzheimer's, Parkinson's, and epilepsy.
NEUROShield requires 3D T1 MPRAGE or BRAVO or FFE DICOM files for image input. While it provides volumetric analysis, it's important to remember that AI tools are decision support systems and not a substitute for clinical judgment.
NEUROShield is FDA 510(k) cleared as a clinical decision-support tool. The platform is designed with HIPAA-aligned access control, ensuring patient data is only visible to authorized personnel, and all predictions are logged in an audit trail.
Yes, several other AI tools offer neurological support. These include platforms like OpenEvidence for cross-specialty knowledge, MedLink AI for evidence-based neurology, Viz.ai/RapidAI for neuroimaging and emergency triage in stroke, and Vera Health for acute and general neurology. Ambient AI scribing tools like DeepCura AI and FreedAI also assist with administrative workflows.
The provided information does not specify the pricing model for NEUROShield for medical professionals. However, InMed AI's mission includes bringing affordable and accessible healthcare tools to everyone.

Related Tools

Parkiwatch
Koios Care
Neurology AI
Parkiwatch by Koios Care is a Class IIa Software as a Medical Device (EU MDR 2017/745) for continuous, passive detection and quantitative assessment of kinematic patterns representative of tremor, bradykinesia, and dyskinesia in adults with Parkinson's Disease.
Paid
CortiCare (Virtual EEG Department)
CortiCare
Neurology AI
CortiCare offers 24/7 remote EEG monitoring and interpretation services, functioning as a virtual EEG department to assist hospitals and neurology practices in identifying seizures and other neurological conditions.
NeuroAstra
Avinya NeuroTech
Clinical Decision Support & Reference
NeuroAstra is an AI-enabled EEG analysis and reporting software that provides a multimodal clinical EEG web platform with Co-Pilot AI to help neuro care teams detect abnormal trends faster and standardize reporting.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.